The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Ras oncogenes: split personalities
Open accessAbstract
Extensive research on the Ras proteins and their functions in cell physiology over the past 30 years has led to numerous insights that have revealed the involvement of Ras not only in tumorigenesis but also in many developmental disorders. Despite great strides in our understanding of the molecular and cellular mechanisms of action of the Ras proteins, the expanding roster of their downstream effectors and the complexity of the signalling cascades that they regulate indicate that much remains to be learnt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PDEδ has a large hydrophobic pocket that can bind farnesyl proteins, especially the lipid portion of KRAS protein, thereby preventing the farnesyl modification of KRAS protein from binding to cell membrane and inhibiting tumor cell proliferation and growth.339,340”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [339]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,405
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Srimaroeng, C., Cecile, J. P., Walden, R., & Pritchard, J. B. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350077 · Cited by 2,989
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationPhosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Mammalian Ras interacts directly with the serine/threonine kinase raf
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,934
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R. B., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,736
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Annual review of KRAS inhibitors in 2022
Wang, H., Chi, L., Yu, F., Dai, H., Gao, C., Si, X., Wang, Z., Liu, L., Zheng, J., Shan, L., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115124 · Cited by 53
Dynamic Palmitoylation and the Role of DHHC Proteins in T Cell Activation and Anergy
Ladygina, N., Martin, B. R., & Altman, A. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387664-5.00001-7 · Cited by 50
Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target
Chen, M., Peters, A., Huang, T., & Nan, X. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666151001152212 · Cited by 49
Membrane orientation dynamics of lipid-modified small GTPases
Prakash, P., & Gorfe, A. A. (2016) · Small GTPases · doi:10.1080/21541248.2016.1211067 · Cited by 48
Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
Carvalho, P. D., Machado, A. L., Martins, F., Seruca, R., & Velho, S. (2019) · Cancers · doi:10.3390/cancers11122010 · Cited by 49
Structural basis of GDP release and gating in G protein coupled Fe2+ transport
Guilfoyle, A. P., Maher, M. J., Rapp, M., Clarke, R. J., Harrop, S. J., & Jormakka, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.208 · Cited by 48
Emerging Roles for Intersectin (ITSN) in Regulating Signaling and Disease Pathways
Hunter, M. P., Russo, A., & O’Bryan, J. P. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047829 · Cited by 47
ADP-Ribosylarginine Hydrolase Regulates Cell Proliferation and Tumorigenesis
Kato, J., Zhu, J., Liu, C., Stylianou, M. P., Hoffmann, V. J., Lizak, M. J., Glasgow, C. G., & Moss, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0733 · Cited by 49
Matsumoto, S., Miyano, N., Baba, S., Liao, J., Kawamura, T., Tsuda, C., Takeda, A., Yamamoto, M., Kumasaka, T., Kataoka, T., et al. (2016) · Scientific Reports · doi:10.1038/srep25931 · Cited by 48
Targeting FBPase is an emerging novel approach for cancer therapy
Liu, G., & Zhang, Y.-M. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0533-z · Cited by 47
HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer
Sugita, S., Enokida, H., Yoshino, H., Miyamoto, K., Yonemori, M., Sakaguchi, T., Osako, Y., & Nakagawa, M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4435 · Cited by 47
An Integrated Global Analysis of Compartmentalized HRAS Signaling
Santra, T., Herrero, A., Rodríguez, J., von Kriegsheim, A., Iglesias-Martinez, L. F., Schwarzl, T., Higgins, D. G., Aye, T., Heck, A. J. R., Calvo, F., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.038 · Cited by 47
Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer
Cruz, V. H., Arner, E. N., Du, W., Bremauntz, A. E., & Brekken, R. A. (2019) · JCI Insight · doi:10.1172/jci.insight.126117 · Cited by 47
Garant, K. A., Shmulevitz, M., Pan, L., Daigle, R., Ahn, D.-G., Gujar, S. A., & Lee, P. W. K. (2015) · Oncogene · doi:10.1038/onc.2015.136 · Cited by 47
Taşkın, E., Akgün‐Dar, K., Kapucu, A., Osanç, E., Doğruman, H., Eraltan, H., & Ulukaya, E. (2009) · Cell Biochemistry and Function · doi:10.1002/cbf.1604 · Cited by 47
Charette, N., Saeger, C. D., Lannoy, V., Horsmans, Y., Leclercq, I. A., & Stärkel, P. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-256 · Cited by 48
Chakraborty, J., Chakraborty, S., Chakraborty, S., & Narayan, M. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194988 · Cited by 47
USP7 deubiquitinates KRAS and promotes non-small cell lung cancer
Huang, B., Cao, D., Yuan, X., Xiong, Y., Chen, B., Wang, Y., Niu, X., Tian, R., & Huang, H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114917 · Cited by 47
Tetsu, O., Phuchareon, J., Chou, A. Y., Cox, D. P., Eisele, D. W., & Jordan, R. C. (2010) · Neoplasia · doi:10.1593/neo.10356 · Cited by 46
Zhou, Z., Patel, M., Ng, N., Hsieh, M. H., Orth, A. P., Walker, J. R., Batalov, S., Harris, J. L., & Liu, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-944 · Cited by 46
Preethi, S., Schomay, T. E., Aiello, K. A., & Alter, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121396 · Cited by 46
Chen, X., Makarewicz, J., Knauf, J. A., Johnson, L. K., & Fagin, J. A. (2013) · Oncogene · doi:10.1038/onc.2013.489 · Cited by 48
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
Shankar, S., Tien, J. C.-Y., Siebenaler, R. F., Chugh, S., Dommeti, V. L., Zelenka-Wang, S., Waninger, J. J., Juckette, K. M., Xu, A., Wang, X.-M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16309-2 · Cited by 47
Camolotto, S. A., Belova, V. K., Torre-Healy, L. A., Vahrenkamp, J. M., Berrett, K. C., Conway, H., Shea, J., Stubben, C., Moffitt, R. A., Gertz, J., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321316 · Cited by 46
Chen, J., Wang, W., Pang, L., & Zhu, W. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp03766d · Cited by 45
Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab
Liu, S., Yan, S., Zhu, J., Lu, R., Kang, C., Tang, K. L., Zeng, J., Ding, M., Guo, Z., Lai, X., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169014 · Cited by 46
Uniyal, P., Kashyap, V. K., Behl, T., Parashar, D., & Rawat, R. (2025) · Cancers · doi:10.3390/cancers17050785 · Cited by 48
Ras-Induced Changes in H3K27me3 Occur after Those in Transcriptional Activity
Hosogane, M., Funayama, R., Nishida, Y., Nagashima, T., & Nakayama, K. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003698 · Cited by 46
A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation
Bentley, C., Jurinka, S. S., Kljavin, N. M., Vartanian, S., Ramani, S. R., Gonzalez, L. C., Yu, K., Modrusan, Z. D., Du, P., Bourgon, R., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121578 · Cited by 45
A Systems Perspective of Ras Signaling in Cancer
Stites, E. C., & Ravichandran, K. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2753 · Cited by 46
Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells
Kwon, T., Bak, Y., Park, Y., Jang, G.-B., Nam, J., Yoo, J. E., Park, Y. N., Bak, I. S., Kim, J., Yoon, D., et al. (2016) · Stem Cells · doi:10.1002/stem.2323 · Cited by 46
KRAS Engages AGO2 to Enhance Cellular Transformation
Shankar, S., Pitchiaya, S., Malik, R., Kothari, V., Hosono, Y., Yocum, A. K., Gundlapalli, H., White, Y. N., Firestone, A. J., Cao, X., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.034 · Cited by 46
An, J. H., Song, K., Kim, S. K., Park, K. S., Yoo, Y. B., Yang, J., Hwang, T. S., & Kim, D. (2014) · Clinical Endocrinology · doi:10.1111/cen.12579 · Cited by 45
Vuoriluoto, K., Högnäs, G., Meller, P., Lehti, K., & Ivaska, J. (2011) · Matrix Biology · doi:10.1016/j.matbio.2011.03.003 · Cited by 45
Cirstea, I. C., Gremer, L., Dvorský, R., Zhang, S.-C., Piekorz, R. P., Zenker, M., & Ahmadian, M. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds426 · Cited by 45
Oligomerization and nanocluster organization render specificity
Nussinov, R., Jang, H., & Tsai, C. (2014) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12124 · Cited by 44
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK
Vogel, C., Smit, M. A., Maddalo, G., Possik, P. A., Sparidans, R. W., van der Burg, S. H., Verdegaal, E. M. E., Heck, A. J. R., Samatar, A. A., Beijnen, J. H., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12364 · Cited by 44
Omerović, J., Clague, M. J., & Prior, I. A. (2009) · Biochemical Journal · doi:10.1042/bj20091413 · Cited by 44
Proteomic analysis of peritrophic membrane (PM) from the midgut of fifth-instar larvae, Bombyx mori
Hu, X., Chen, L., Xiang, X., Yang, R., Yu, S., & Wu, X. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1114-6 · Cited by 44
Schlaeth, M., Berger, S., Derer, S., Klausz, K., Lohse, S., Dechant, M., Lazar, G. A., Schneider‐Merck, T., Peipp, M., & Valerius, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01505.x · Cited by 44
Whyte, M. P., Griffith, M., Trani, L., Mumm, S. R., Gottesman, G. S., McAlister, W. H., Krysiak, K., Lesurf, R., Skidmore, Z. L., Campbell, K. M., et al. (2017) · Bone · doi:10.1016/j.bone.2017.04.010 · Cited by 44
There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma
Wrighton, P. J., Oderberg, I. M., & Goessling, W. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.05.002 · Cited by 44
Cten Is Targeted by Kras Signalling to Regulate Cell Motility in the Colon and Pancreas
Alghamdi, S. A. A., Albasri, A. M., Cachat, J., Ibrahem, S., Muhammad, B. A., Jackson, D., Nateri, A. S., Kindle, K. B., & Ilyas, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020919 · Cited by 44
Erratum: Ras and Raf pathways in epidermis development and carcinogenesis
Kern, F., Niault, T., & Baccarini, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.108 · Cited by 44
Batista, W. L., Ogata, F. T., Curcio, M. F., Miguel, R. B., Arai, R. J., Matsuo, A. L., de Moraes, M. S., Stern, A., & Monteiro, H. P. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4455 · Cited by 43
Gremer, L., Luca, A. D., Merbitz-Zahradnik, T., Dallapiccola, B., Morlot, S., Tartaglia, M., Kutsche, K., Ahmadian, M. R., & Rosenberger, G. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp548 · Cited by 43
The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics
Nagdas, S., & Kashatus, D. F. (2017) · Antioxidants · doi:10.3390/antiox6020033 · Cited by 46
Nakhaei‐Rad, S., Haghighi, F., Nouri, P., Adariani, S. R., Lissy, J., Jasemi, N. S. K., Dvorský, R., & Ahmadian, M. R. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1431605 · Cited by 44
Acute lymphoblastic leukemia in the context of RASopathies
Cavé, H., Caye‐Eude, A., Strullu, M., Aladjidi, N., Vignal, C., Ferster, A., Mechinaud, F. M., Domenech, C., Pierri, F., Contet, A., et al. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.01.003 · Cited by 43
What makes oncogenes mutually exclusive?
Cisowski, J., & Bergö, M. O. (2016) · Small GTPases · doi:10.1080/21541248.2016.1212689 · Cited by 48
Šuštić, T., van Wageningen, S., Bosdriesz, E., Reid, R. J. D., Dittmar, J., Lieftink, C., Beijersbergen, R. L., Wessels, L. F. A., Rothstein, R., & Bernards, R. (2018) · Genome Medicine · doi:10.1186/s13073-018-0600-z · Cited by 42
Hedgehog Signaling and Pancreatic Tumor Development
Lauth, M., & Toftgård, R. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00001-3 · Cited by 43
Yaman, E., Gasper, R., Koerner, C., Wittinghofer, A., & Tazebay, U. H. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07166.x · Cited by 42
Cushman‐Vokoun, A. M., Stover, D. G., Zhao, Z., Koehler, E., Berlin, J. D., & Vnencak‐Jones, C. L. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.04.005 · Cited by 42
DEPTOR regulates vascular endothelial cell activation and proinflammatory and angiogenic responses
Bruneau, S., Nakayama, H., Woda, C. B., Flynn, E. A., & Briscoe, D. M. (2013) · Blood · doi:10.1182/blood-2013-03-488486 · Cited by 43
Deng, Z., Wang, L., Hou, H., Zhou, J., & Xu, L. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3228 · Cited by 42
Banerjee, A., Jang, H., Nussinov, R., & Gaponenko, V. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.11.010 · Cited by 42
Nussinov, R., Tsai, C., Muratcioğlu, S., Jang, H., Gürsoy, A., & Keskin, Ö. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1100079 · Cited by 42
Llauradó, M., DiMattia, G. E., Dawson, A., Bamford, S., Anderson, S. A., Hennessy, B. T., Anglesio, M. S., Shepherd, T. G., Salamanca, C. M., Hoenisch, J., et al. (2016) · PubMed Central · Cited by 42
Li, S., Hua, W., Wang, K., Gao, Y., Chen, S., Liu, W., Song, Y., Wu, X., Tu, J., Kang, L., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.012 · Cited by 43
Nisha, K., Janam, P., & Harsha Kumar, K. (2019) · Journal of Periodontology · doi:10.1002/jper.18-0729 · Cited by 42
Gupta, A. K., Wang, X., Pagba, C. V., Prakash, P., Sarkar‐Banerjee, S., Putkey, J. A., & Gorfe, A. A. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13519 · Cited by 43
Porther, N., & Barbieri, M. (2015) · Small GTPases · doi:10.1080/21541248.2015.1050152 · Cited by 42
Kusumoto, A., Nishioka, N., Kojima, S., & Homma, M. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp109 · Cited by 41
Discovery of oncogenes: The advent of molecular cancer research
Bister, K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521145112 · Cited by 41
Köseoğlu, M. M., Norambuena, A., Sharlow, E. R., Lazo, J. S., & Bloom, G. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180874 · Cited by 41
Mercher, T., & Schwaller, J. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00401 · Cited by 42
Wang, X., Shu, G., Gao, C., Yang, Y., Xu, Q., & Tang, M. X. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.08.023 · Cited by 41
Chen, L., Fu, Y., Ren, M., Xiao, B., & Rubin, C. S. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.039 · Cited by 41
Oncogenic MAP2K1 mutations in human epithelial tumors
Choi, Y. L., Soda, M., Ueno, T., Hamada, T., Haruta, H., Yamato, A., Fukumura, K., Ando, M., Kawazu, M., Yamashita, Y., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs099 · Cited by 42
Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence
Shin, J., Yang, J., Lee, J. C., & Baek, K. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.014 · Cited by 41
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
Aldea, M. D., Craciun, L., Tomuleasa, C., Berindan‐Neagoe, I., Kacsó, G., Florian, I. Ş., & Crivii, C. B. (2014) · Tumor Biology · doi:10.1007/s13277-014-1676-8 · Cited by 44
Kim, M., Chen, X., Chin, L. J., Paranjape, T., Speed, W. C., Kídd, K. K., Zhao, H., Weidhaas, J. B., & Slack, F. J. (2014) · Cell Cycle · doi:10.4161/cc.27941 · Cited by 41
miRNA interventions serve as ‘magic bullets’ in the reversal of glioblastoma hallmarks
Chen, L., & Kang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.5926 · Cited by 40
Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK – ERK pathway
Hu, Y., Yang, L., Yang, Y., Han, Y., Wang, Y., Liu, W., & Zuo, J. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12905 · Cited by 40
MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer
Stefan, E., & Bister, K. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_4 · Cited by 40
Kitano, Y., Baba, Y., Nakagawa, S., Miyake, K., Iwatsuki, M., Ishimoto, T., Yamashita, Y., Yoshida, N., Watanabe, M., Nakao, M., et al. (2017) · The Journal of Pathology · doi:10.1002/path.5021 · Cited by 40
Peng, W., Zhi-yin, S., Zhang, Q., Cheng, S.-Q., Wang, S., Wang, X., Kuang, G., Su, X., Tan, J., Huang, Z., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00257 · Cited by 40
Structural snapshots of RAF kinase interactions
Adariani, S. R., Buchholzer, M., Akbarzadeh, M., Nakhaei‐Rad, S., Dvorský, R., & Ahmadian, M. R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20170528 · Cited by 41
Annexin A2 Regulates AKT Upon H2O2-Dependent Signaling Activation in Cancer Cells
Castaldo, S. A., Ajime, T., Serrão, G., Anastácio, F., Rosa, J. T., Giacomantonio, C. A., Howarth, A., Hill, R., & Madureira, P. A. (2019) · Cancers · doi:10.3390/cancers11040492 · Cited by 40
The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor
Zhang, X., Murray, B., Mo, G., & Shern, J. F. (2020) · Genes · doi:10.3390/genes11030287 · Cited by 43
Sk, U. H., & Bhattacharya, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_126-1 · Cited by 40
Biophysical Mechanism for Ras-Nanocluster Formation and Signaling in Plasma Membrane
Gurry, T., Kahramanoğulları, O., & Endres, R. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006148 · Cited by 40
Liu, S., Wang, H., Zhang, L., Tang, C., Jones, L. E., Ye, H., Ban, L., Wang, A., Liu, Z., Lou, F., et al. (2015) · Human Genomics · doi:10.1186/s40246-015-0024-4 · Cited by 39
González, R., Molina-Ruiz, F. J., Bárcena, J. A., Padilla, C. A., & Muntané, J. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7072 · Cited by 39
Kong, F., Kong, X., Du, Y., Chen, Y., Deng, X., Zhu, J., Du, J., Li, L., Jia, Z., Xie, D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0067 · Cited by 39
Exceptionally high-affinity Ras binders that remodel its effector domain
McGee, J. H., Shim, S. Y., Lee, S., Swanson, P. K., Jiang, S. Y., Durney, M. A., & Verdine, G. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.816348 · Cited by 40
Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition
Tan, S. C. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3010 · Cited by 39
Sanz-Rodríguez, M., Gruart, A., Escudero‐Ramirez, J., de Castro, F., Delgado-Garcia, J. M., Wandosell, F. G., & Cubelos, B. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3364-17.2018 · Cited by 42
Computational Structural Biology of S-nitrosylation of Cancer Targets
Bignon, E., Allega, M. F., Lucchetta, M., Tiberti, M., & Papaleo, E. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00272 · Cited by 39
Pálfy, G., Vida, I., & Perczel, A. (2019) · Biomolecular NMR Assignments · doi:10.1007/s12104-019-09909-7 · Cited by 39
Kent, O. A., Saha, M., Coyaud, É., Burston, H. E., Law, N., Dadson, K., Chen, S., Laurent, E. M. N., St‐Germain, J. R., Sun, R. X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18483-9 · Cited by 41
Emerging Roles of Small GTPases in Islet β-Cell Function
Veluthakal, R., & Thurmond, D. C. (2021) · Cells · doi:10.3390/cells10061503 · Cited by 43
Chen, J., Zeng, Q., Wang, W., Hu, Q., & Bao, H. (2022) · RSC Advances · doi:10.1039/d1ra07936k · Cited by 39
DNA methylation‐mediated nucleosome dynamics and oncogenic Ras signaling
Patra, S. K., & Szyf, M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06658.x · Cited by 39
Intrinsic GTPase activity of K-RAS monitored by native mass spectrometry
Moghadamchargari, Z., Huddleston, J., Shirzadeh, M., Zheng, X., Clemmer, D. E., M. Raushel, F., Russell, D. H., & Laganowsky, A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00532 · Cited by 38
Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants
Moghadamchargari, Z., Shirzadeh, M., Liu, C., Schrecke, S., Packianathan, C., Russell, D. H., Zhao, M., & Laganowsky, A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022403118 · Cited by 38
New structural and functional insight into the regulation of Ras
Kano, Y., Cook, J. D., Lee, J. E., & Ohh, M. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.06.006 · Cited by 38
Oncogenic role of EAPII in lung cancer development and its activation of the MAPK–ERK pathway
Li, C., Fan, S., Owonikoko, T. K., Khuri, F. R., Sun, S.-Y., & Li, R. (2011) · Oncogene · doi:10.1038/onc.2011.94 · Cited by 38
Covalent Ras Dimerization on Membrane Surfaces through Photosensitized Oxidation
Chung, J. K., Lee, Y. K., Lam, H. Y. M., & Groves, J. T. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12648 · Cited by 38
Metadata
- Authors
- Karnoub, A. E., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-07
- Volume
- 9
- Issue
- 7
- Pages
- 517-531
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC3915522
- OpenAlex
- W2004774286
- Cited by
- 1,467
- References
- 234
- Citations by year
- 2026: 28 · 2025: 48 · 2024: 58 · 2023: 60 · 2022: 67 · 2021: 89 · 2020: 74 · 2019: 87 · 2018: 93 · 2017: 95 · 2016: 103 · 2015: 118 · 2014: 100 · 2013: 108 · 2012: 94
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P01 CA08111, U54 CA12515, P01CA080111, P50CA089393)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- oncogenic Ras, carcinogenesis, developmental disorders, downstream effectors, cell physiology, Ras proteins
- MeSH terms
- Amino Acid Sequence, Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Enzyme Activation, Gene Expression Regulation, Humans, Models, Molecular, Molecular Sequence Data, Phylogeny, Protein Conformation, Protein Processing, Post-Translational, Genes, ras, Transcription Factors, Signal Transduction, Sequence Alignment, ras Proteins, Phosphatidylinositol 3-Kinases, GTPase-Activating Proteins, Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review